A phase 1/2 study of Ad.p53 DC vaccine with indoximod immunotherapy in metastatic breast cancer

Authors
Category Primary study
JournalCancer Research
Year 2015
This article has no abstract
Epistemonikos ID: 1d25a260c282d3e908e05c511c0724299fa80605
First added on: Feb 07, 2025